Renaissance Technologies - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 174 filers reported holding NEVRO CORP in Q4 2016. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$3,877
-52.1%
201,700
-36.6%
0.01%
-41.7%
Q2 2023$8,089
-48.2%
318,200
-26.3%
0.01%
-42.9%
Q1 2023$15,613
+57.8%
431,900
+72.8%
0.02%
+50.0%
Q4 2022$9,896
-99.3%
249,900
+741.4%
0.01%
+600.0%
Q3 2022$1,384,000
+110.7%
29,700
+98.0%
0.00%
+100.0%
Q2 2022$657,000
-89.0%
15,000
-81.9%
0.00%
-85.7%
Q1 2022$5,982,000
+69.6%
82,700
+90.1%
0.01%
+75.0%
Q4 2021$3,527,000
-84.6%
43,500
-73.5%
0.00%
-85.7%
Q1 2021$22,878,000
+1208.8%
164,000
+1523.8%
0.03%
+1300.0%
Q4 2020$1,748,000
-88.3%
10,100
-90.6%
0.00%
-86.7%
Q3 2020$14,947,000
-53.2%
107,300
-59.9%
0.02%
-46.4%
Q2 2020$31,946,000
-18.8%
267,400
-32.1%
0.03%
-26.3%
Q1 2020$39,354,000
+49.4%
393,617
+75.6%
0.04%
+90.0%
Q4 2019$26,341,000
+218.9%
224,100
+75.9%
0.02%
+185.7%
Q2 2019$8,259,000
-34.2%
127,400
-36.6%
0.01%
-36.4%
Q1 2019$12,558,000
+67.1%
200,900
+179.0%
0.01%
-15.4%
Q3 2016$7,516,000
+19.2%
72,000
-15.8%
0.01%
+8.3%
Q2 2016$6,306,000
-1.9%
85,500
-28.5%
0.01%
-20.0%
Q2 2015$6,429,000119,6000.02%
Other shareholders
NEVRO CORP shareholders Q4 2016
NameSharesValueWeighting ↓
Tiger Eye Capital LLC 239,122$41,392,0008.25%
Integral Health Asset Management, LLC 88,000$15,233,0004.53%
Iron Triangle Partners LP 168,761$29,213,0003.79%
Eos Focused Equity Management, L.P. 14,002$2,424,0002.37%
PFM Health Sciences, LP 311,940$53,997,0001.90%
Perceptive Advisors 977,565$169,217,0001.82%
Rock Springs Capital Management LP 395,000$68,375,0001.45%
Lisanti Capital Growth, LLC 54,302$9,400,0001.30%
HealthCor Management, L.P. 156,046$27,012,0001.04%
FRED ALGER MANAGEMENT, LLC 2,136,612$369,848,0000.96%
View complete list of NEVRO CORP shareholders